CIK 0001650648 · Non-accelerated filer<br>Smaller reporting company
4D Molecular Therapeutics, Inc.
Sign in to watch- Ticker
- FDMT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 473506994
- Phone
- 5105052680
- Business address
- 5858 HORTON STREET #455, EMERYVILLE, CA, 94608
- Former names
- 4D Molecular Therapeutics Inc., 4D Molecular Therapeutics Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,724,648
- in 7 filings, $2.7M under 10b5-1 plans
Net −$2,724,648. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-24 | Kirn David Chief Executive Officer | Option exercise 10b5-1 | +12,930 | $14.42 | $186K | 1,072,083 |
| 2024-06-24 | Kirn David Chief Executive Officer | Sale 10b5-1 | −12,930 | $23.10 | $299K | 1,059,153 |
| 2024-06-24 | Kirn David Chief Executive Officer | Option exercise · Stock Option (Right To Buy) 10b5-1 | −12,930 | 577,070 | ||
| 2024-06-17 | Bizily Scott Chief Legal Officer | Option exercise 10b5-1 | +500 | $6.49 | $3K | 2,237 |
| 2024-06-17 | Bizily Scott Chief Legal Officer | Option exercise 10b5-1 | +1,250 | $8.04 | $10K | 3,487 |
| 2024-06-17 | Bizily Scott Chief Legal Officer | Sale 10b5-1 | −1,750 | $23.71 | $41K | 1,737 |
| 2024-06-17 | Bizily Scott Chief Legal Officer | Option exercise · Stock Option (Right To Buy) 10b5-1 | −500 | 13,211 | ||
| 2024-06-17 | Bizily Scott Chief Legal Officer | Option exercise · Stock Option (Right To Buy) 10b5-1 | −1,250 | 36,668 | ||
| 2024-05-21 | Tomasello Shawn Director | Grant or award · Stock Option (Right To Buy) | +22,500 | 22,500 | ||
| 2024-05-21 | Chacko Jacob Director | Grant or award · Stock Option (Right To Buy) | +22,500 | 22,500 | ||
| 2024-05-21 | THEUER CHARLES Director | Grant or award · Stock Option (Right To Buy) | +22,500 | 22,500 | ||
| 2024-05-21 | Miller-Rich Nancy Director | Grant or award · Stock Option (Right To Buy) | +22,500 | 22,500 | ||
| 2024-05-21 | MILLIGAN JOHN F Director | Grant or award · Stock Option (Right To Buy) | +26,791 | 26,791 | ||
| 2024-05-21 | GRAY SUSANNAH Director | Grant or award · Stock Option (Right To Buy) | +22,500 | 22,500 | ||
| 2024-05-16 | Bizily Scott Chief Legal Officer | Option exercise 10b5-1 | +500 | $6.49 | $3K | 2,237 |
| 2024-05-16 | Bizily Scott Chief Legal Officer | Option exercise 10b5-1 | +1,250 | $8.04 | $10K | 3,487 |
| 2024-05-16 | Bizily Scott Chief Legal Officer | Sale 10b5-1 | −1,283 | $25.34 | $33K | 2,204 |
| 2024-05-16 | Bizily Scott Chief Legal Officer | Sale 10b5-1 | −467 | $25.75 | $12K | 1,737 |
| 2024-05-16 | Bizily Scott Chief Legal Officer | Option exercise · Stock Option (Right To Buy) 10b5-1 | −500 | 13,711 | ||
| 2024-05-16 | Bizily Scott Chief Legal Officer | Option exercise · Stock Option (Right To Buy) 10b5-1 | −1,250 | 37,918 |
Page 7 of 16 · 319 trades